Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Bin Yang

机构:Tongji University, Shanxi Agricultural University, Fujian Medical University, Chinese Academy of Sciences, First Affiliated Hospital of Xiamen University, Second Affiliated Hospital of Guangzhou Medical University, First Affiliated Hospital of Fujian Medical University, General Hospital of Shenyang Military Region, Shanghai Tenth People's Hospital, Zhejiang Institute of Science and Technology Information, Shanxi Normal University, Collaborative Innovation Center of Advanced Microstructures, Technical Institute of Physics and Chemistry, Tongji Hospital, Shanxi Academy of Agricultural Sciences, University of Chinese Academy of Sciences, Hubei Normal University, Huazhong University of Science and Technology, Nanjing University, Guangzhou Medical University · ORCID:0000-0002-3944-8035

发表论文 173 篇 · 总被引 2064 次 · h-index 23

代表论文

  • CircCNOT6L modulates alternative splicing of SLC7A11 via splicing factor SRSF2 to confer ferroptosis resistance and promote metastasis in prostate cancer (2025 · Experimental & Molecular Medicine · 被引 7)
  • CD47-targeted liposomal chemotherapy upregulates CD47 expression and induces microsatellite instability which enhances cancer immunotherapy (2025 · Journal of Controlled Release · 被引 3)
  • Revealing the Interplay of Intraorganellar O 2 •– and ATP in Brain Aging-Related Alzheimer’s Disease via Unimolecular Dual-Responsive Probes (2025 · Analytical Chemistry · 被引 3)
  • Comparison of combined MRI-TRUS fusion targeted and systematic biopsy vs systematic biopsy alone for the detection of prostate cancer in the Chinese biopsy-naïve patients: a prospective, single-center trial (2025 · International Journal of Surgery · 被引 2)
  • Enhancing immunotherapy in colorectal cancer by immune-modulatory and lipid-metabolism reprogramming with host-guest co-delivery nanoplatform (2025 · Chemical Engineering Journal · 被引 1)
  • Figure 3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study (2025)